Codeine Phosphate

Quick links to important sections

Codeine Phosphate

Method of action: Antitussive Opioid

Treatment option: Pain

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Codeine Phosphate

Property Description
Active Ingredient Codeine
Form Tablet, Oral Solution, Injectable
Pharmacological Class Opioid Analgesic, Antitussive
General Purpose Relief of mild to moderate pain and cough suppression
Origin Semi-synthetic (derived from opium alkaloids)

Codeine Phosphate: Classification and Identity

Codeine Phosphate is a semi-synthetic medication classified primarily as an opioid analgesic and an antitussive agent, used for its targeted actions on the central nervous system. The active ingredient, codeine, is a compound derived from natural opium alkaloids found in the poppy plant.

Codeine is uniquely defined as a prodrug because a portion of the administered dose requires hepatic metabolism to be converted into morphine, which is clinically recognized for contributing significantly to its potent analgesic action. This metabolic conversion is a key differentiating factor from other direct-acting opioid medications.

Composition and Forms: Understanding the Preparation

The drug is commonly supplied in various pharmaceutical preparations, including solid tablets and liquid oral solutions, facilitating oral administration for systemic absorption. The compound utilized is Codeine phosphate, the highly soluble chemical salt form selected for its optimal stability and formulation into either aqueous bases or compressed solid dosage forms.

Codeine Phosphate is frequently found in combination formulations, where it is paired with non-opioid substances to treat pain, differentiating this preparation from single-entity opioid agents. This dual capability is a key factor in its therapeutic utility.

Core Purpose: Relief of Pain and Cough

The fundamental purpose of Codeine Phosphate is to provide symptomatic relief by modulating the central nervous system to reduce mild to moderate pain and to suppress the persistent cough reflex. Its dual classification—as both an analgesic and an antitussive—defines its general therapeutic role. This dual utility is a differentiating factor that makes Codeine Phosphate suitable for treating patient discomfort where both pain and a bothersome, unproductive cough are present.

Regulatory References

  1. NIH, MedlinePlus

What side effects are possible with Codeine Phosphate?

Possible Side Effects and Safety Information

The safety profile of Codeine Phosphate is based on mandatory governmental regulatory documents, which classify adverse reactions by frequency and potential severity.

Officially Documented Side Effects

Adverse effects are categorized according to the organ system affected. Common reactions, meaning they may affect more than 1 in 100 people, typically involve the Gastrointestinal and Nervous Systems.

System-Organ Class Common Adverse Reactions
Gastrointestinal Constipation, Nausea, Vomiting, Dry mouth
Nervous System Drowsiness (Somnolence), Dizziness, Confusion, Headache

Serious Safety Warnings

Regulatory authorities document serious, clinically significant risks. The most critical risk is Life-Threatening or Fatal Respiratory Depression, which is noted to be greatest during the initiation of therapy or following a dose increase. Other severe risks include Addiction, Abuse, and Misuse, as well as the risk of Neonatal Opioid Withdrawal Syndrome (NOWS) if the drug is used for prolonged periods during pregnancy.

Population-Specific Safety Constraints

Official labeling mandates specific contraindications for certain populations:

  • Pediatric Contraindication: The medication is generally contraindicated for use in children younger than 12 years of age for all indications.
  • Post-Operative Use: It is contraindicated for pain relief in children and adolescents (under 18 years) following tonsillectomy or adenoidectomy.
  • Breastfeeding: Use is not recommended or contraindicated in women who are breastfeeding due to the risk of serious adverse reactions, including infant respiratory depression, particularly if the mother is an ultra-rapid metabolizer.

Safety-related constraints also restrict use in individuals with significant respiratory issues, acute asthma, or gastrointestinal obstruction (such as paralytic ileus).

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the clinical manifestations of Codeine Phosphate overdose and the required emergency actions as strictly documented in official government regulatory sources.

Overdose is characterized by severe Central Nervous System (CNS) depression and life-threatening respiratory depression. Clinical signs documented in official labeling include excessive drowsiness, stupor, confusion, or progression to coma. The most critical manifestation is slow, shallow, or labored breathing, which can advance to apnea and be fatal, resulting in signs like pinpoint pupils and cyanosis. Cardiovascular effects such as low blood pressure and slow heartbeat may also occur.

Required Emergency Actions

Immediate medical attention must be sought for any suspected overdose. Regulatory guidance mandates that emergency services be contacted immediately if symptoms involve slowed or stopped breathing, long pauses between breaths, or if the individual cannot be woken or respond.

Overdose Management and Risk

Management focuses on reversing the acute effects. The specific opioid antagonist Naloxone is indicated to counter the severe CNS and respiratory depression. Supportive care may involve breathing assistance, such as oxygen and ventilation, and procedures like administering activated charcoal.

Regulatory documents highlight a heightened risk of life-threatening respiratory depression in certain populations, notably in children younger than 12 years and in individuals identified as CYP2D6 ultra-rapid metabolizers. Close monitoring of vital signs is required for overdose cases.

Therapeutic Uses of Codeine Phosphate

What Codeine Phosphate Treats: Main Uses and Benefits

Codeine phosphate is applied across domains where additional symptomatic support is needed, focusing on symptoms associated with acute or episodic changes. This makes it relevant in contexts involving heightened systemic burden and where short-term symptomatic assistance is generally appropriate. It is considered relevant in managing symptoms related to moderate pain and is applied in addressing persistent dry cough.

As an opioid pain reliever, the substance is used for mild to moderately severe pain and is also used to reduce coughing. For many patients, it is applied in clinical settings that involve acute or unstable symptom patterns, such as in managing discomfort after an operation or supporting the patient during episodes of irritative cough.

“This level of support assists with maintaining functional stability.”


Quick Fact: Relief for Acute Discomfort

Codeine may assist with maintaining functional stability by providing supportive relief when symptoms interfere with routine activities. It is often used when symptoms intensify and supportive relief is needed.


Managing Short-Term, Moderate Pain

This medication is applied specifically for pain episodes of moderate intensity (such as dental or post-operative discomfort) in situations where symptoms are creating noticeable physiological strain. It offers symptomatic relief that generally supports general well-being during symptomatic phases.


Quieting Persistent Dry Cough

Codeine is relevant in situations involving certain distressing symptoms caused by a repetitive, non-productive cough. It is commonly used to help address symptom clusters that interfere with daily comfort, and may help patients cope more steadily with symptom fluctuations, especially during nighttime hours.

Eligibility and Restrictions for Use

Official Eligibility Profile for Codeine Phosphate

Regulatory agencies define the eligibility for Codeine Phosphate based on strict constraints to prevent life-threatening adverse effects, primarily respiratory depression. Eligibility is not a general approval but is defined by explicit prohibitions and mandatory restrictions.

Absolute Contraindications (Must Not Use)

  • Age: Children under 12 years of age for any indication.
  • Genetic Status: Individuals who are known CYP2D6 ultra-rapid metabolizers.
  • Post-Surgery: Children and adolescents under 18 years following tonsillectomy and/or adenoidectomy for obstructive sleep apnea.
  • Physiological State: Breastfeeding mothers and patients with acute respiratory depression, severe bronchial asthma, or paralytic ileus.

Restricted or Conditional Use

  • Adolescents (12-18 years): Use is generally restricted and not recommended if other risk factors for respiratory compromise (e.g., severe lung disease, obesity) are present.
  • Organ Function: Use requires caution, and usually dose adjustment, in patients with severe hepatic or renal impairment.
  • Pregnancy: Prolonged use is discouraged due to the risk of neonatal opioid withdrawal syndrome.

What should I know about interactions with other medicines?

Codeine Phosphate can interact with numerous other medicines, potentially increasing side effects or altering the effectiveness of either medication. It is essential to inform your healthcare provider about all prescription, over-the-counter, and herbal products you are taking.

Central Nervous System (CNS) Depressants

Concomitant use of Codeine Phosphate with other CNS depressants, including alcohol, sedatives, hypnotics (sleeping pills), anesthetics, tranquilizers, and certain antihistamines, can lead to additive CNS effects. This can result in profound sedation, respiratory depression, coma, and even death. This combination should generally be avoided, and if necessary, monitored closely by a healthcare professional.

Interacting Drug Class Potential Effect Clinical Management
Monoamine Oxidase Inhibitors (MAOIs) Potentially life-threatening reactions including serotonin syndrome or enhanced CNS depression. Avoid co-administration; a washout period of at least 14 days is typically required after stopping an MAOI.
CYP2D6 Inhibitors (e.g., fluoxetine, paroxetine, quinidine) Codeine is metabolized to the active compound, morphine, by the CYP2D6 enzyme. Inhibitors may reduce this conversion, leading to decreased analgesic efficacy and insufficient pain relief. Consider an alternative analgesic not dependent on CYP2D6 for activation.

Other Interactions

Opioid antagonists like naltrexone block the effects of codeine and are contraindicated. Codeine should be used with caution alongside tricyclic antidepressants due to the increased risk of severe CNS and respiratory depression. Similarly, co-administration with serotonergic drugs (including certain antidepressants) carries a risk of serotonin syndrome.

Mechanism of Action

Prodrug Bioactivation and Central Receptor Agonism

Codeine functions as a prodrug, meaning its mechanism is dependent on its metabolic conversion into the active metabolite, morphine, via the CYP2D6 enzyme in the liver. Morphine then acts as an agonist at the mu-opioid receptors ( MOR) found throughout the Central Nervous System ( CNS). This enzymatic cascade initiates the physiological effect by engaging the primary molecular target.


Modulation of Nociceptive Signal Transmission

Activation of MOR throughout the spinal cord and brainstem initiates an inhibitory G-protein cascade, leading to the hyperpolarization of nerve cells and the pre-synaptic inhibition of excitatory neurotransmitter release. This mechanism directly interferes with and dampens the ascending transmission of nociceptive signals, which is the physiological basis for the central action.


Direct CNS Reflex Suppression

Independently of the analgesic cascade, the drug also exerts a direct effect on the Afferent Reflex Pathway by binding to opioid receptors within the medullary cough centre of the brainstem. This action reduces the sensitivity and excitability of these specific neuronal clusters, leading to a physiological elevation of the neural threshold required to activate the medullary cough centre.


Mechanistic Constraint and Variability

The function of the analgesic mechanism is inherently constrained by genetic polymorphism in the CYP2D6 enzyme. Individuals who are Poor Metabolizers cannot efficiently perform the necessary prodrug conversion, resulting in inadequate generation of the active morphine metabolite and thus insufficient MOR agonism to modulate the nociceptive signaling pathway.

Dosage and Administration Information

Official Administration and Dosage Guidelines

Codeine phosphate is administered through various approved routes, including the oral route for tablets and solutions, as well as parenteral routes such as intramuscular (IM), subcutaneous (SC), and slow intravenous (IV) injection. For oral preparations, the medicine may be taken with or without food. Liquid forms require the use of a calibrated device to ensure accurate measuring.

Administration follows an as-needed (p.r.n.) schedule, typically in divided doses. The standard minimum interval between doses is not less than 4 to 6 hours. For pain management, the standard adult dose ranges from 15 mg to 60 mg per administration, with the maximum daily dose generally limited to 240 mg to 360 mg, depending on the specific formulation and regional guidelines.

Duration of Use and Adjustments

Guidelines generally specify using the lowest effective dose for the shortest possible duration. For acute pain relief, the duration of use is often limited to a maximum of 3 days in alignment with typical pharmaceutical guidelines in various regions. Dosing is adjusted for certain populations: a dose reduction is typically required for older adults (geriatric patients) and individuals with renal or hepatic impairment, reflecting variations in drug clearance.

Use is contraindicated in all children younger than 12 years of age for all indications and is not recommended in adolescents with compromised respiratory function.

Recent Clinical Evidence

Codeine Phosphate: Research Evidence

Pharmacological Research

Studies have explored the activity of codeine, noting that it is a prodrug that requires metabolism to an active compound, primarily morphine, via the CYP2D6 liver enzyme. This pathway's variability across individuals is a central area of investigation, affecting how patients may respond to treatment. Research confirms that differences in CYP2D6 enzyme activity can significantly impact the drug's effectiveness and safety profile.

Clinical Efficacy Trials

Large-scale trials continue to evaluate codeine's utility in mild to moderate pain management and as an antitussive (cough suppressant).

Research confirms its established efficacy for short-term pain relief, typically utilized when non-opioid options are insufficient. Studies comparing codeine to placebo consistently demonstrate a statistically significant analgesic effect, especially when combined with acetaminophen or aspirin.

Area of Research Key Research Focus
Genetics Impact of CYP2D6 polymorphisms on pain relief and adverse event incidence.
Pediatrics Safety concerns regarding ultra-rapid metabolism in children, leading to restricted use.

Safety and Risk Profile

Recent research emphasizes the importance of understanding the risk of respiratory depression, particularly in individuals who are ultra-rapid metabolizers. Studies also continue to examine the potential for dependence and misuse, underscoring its scheduled status. Research supports the current clinical guidance focusing on codeine's use for short durations and at the lowest effective doses.

Key Studies & References

  1. Codeine for Acute Dental Pain and Acute Pain Related to Dental Procedures (Systematic Review Summary)
  2. Codeine - StatPearls (Monograph on mechanism and adverse effects)

Frequently Asked Questions (FAQ)

Common questions about Codeine Phosphate (FAQ)

Q: What is the main difference between codeine and hydrocodone, generally speaking?

A: According to official classifications, codeine is a naturally occurring opioid. Hydrocodone, on the other hand, is a semi-synthetic opioid. These differences are reflected in their regulatory status; for example, in the United States, hydrocodone is often classified as a Schedule II controlled substance, while codeine formulations can fall under Schedule II, III, or V depending on the concentration.

Q: Is Codeine Phosphate considered a strong pain reliever compared to common over-the-counter options?

A: Official documents classify codeine as a weak opioid for pain management. Its use is generally considered when non-opioid options, such as acetaminophen or ibuprofen, have been determined to be insufficient for treating mild to moderate pain.

Q: Can Codeine Phosphate cause drowsiness or affect my ability to drive?

A: According to the official product information, common adverse effects include drowsiness, dizziness, and confusion. Due to these effects, regulatory information describes restrictions regarding driving or operating heavy machinery until the effects of the medication on coordination and alertness are known.

Q: How quickly does Codeine Phosphate typically start working for pain or cough?

A: Official patient information indicates that the effects of codeine, whether taken as a tablet or liquid, typically begin within 30 to 60 minutes of administration.

Q: How long does the effect of a dose of Codeine Phosphate usually last?

A: The analgesic or antitussive effect of a single dose generally lasts for a few hours. This duration aligns with official dosing guidelines, which specify that the minimum interval between doses must be 4 to 6 hours.

Q: Is it possible to have an allergic reaction to Codeine Phosphate?

A: Yes, the official regulatory documents list potential signs of a serious adverse reaction, including symptoms of a hypersensitivity or allergic response. These signs can include a rash, hives, itching, or swelling of the eyes, face, lips, mouth, tongue, or throat.

Q: Does Codeine Phosphate affect sleep patterns?

A: Drowsiness is a common effect, which may naturally alter sleep patterns. In addition, official warnings for opioids note a risk of new or worsened sleep-related breathing disorders, such as unusual snoring or long pauses in breathing during sleep (sleep apnea).

Q: Are there any specific foods or drinks that should be avoided while using Codeine Phosphate?

A: The co-ingestion of alcohol is strongly cautioned against due to the risk of serious additive central nervous system (CNS) depression. Regulatory information states that the drug may be taken with or without food, and there are no specific restrictions on consuming particular foods.

Q: Can Codeine Phosphate be used to treat migraines?

A: Codeine is broadly indicated for the relief of mild to moderate pain. While regulatory documents do not list migraines as a specific primary indication, the drug is sometimes used to manage severe headache symptoms and may be a component in combination products used for this purpose.

Q: What are the known interactions between Codeine Phosphate and antidepressants?

A: According to official documents, Codeine Phosphate has documented interactions with various classes of antidepressants, including Monoamine Oxidase Inhibitors (MAOIs), Tricyclic Antidepressants, and serotonergic drugs. Using these medications together can increase the risk of serious side effects like excessive Central Nervous System (CNS) depression or a potentially life-threatening condition called serotonin syndrome.

Q: What should I look out for if I think I'm having a serious side effect from Codeine Phosphate?

A: Regulatory warnings emphasize observing for signs of life-threatening respiratory depression, such as unusually slowed breathing, shallow breathing, or long pauses between breaths. Other serious safety concerns include watching for signs of severe allergic reaction, such as swelling of the face, lips, or throat, or the sudden onset of a rash or hives.

Q: Is Codeine Phosphate the same as other forms of codeine, like codeine sulfate?

A: Codeine phosphate refers to the specific chemical salt form of codeine used in pharmaceutical preparations, often chosen for its high solubility and stability in tablets or liquids. The active drug itself is codeine. Regulatory documents focus on the effects of the active codeine base rather than the minor differences between its various salt forms.

Q: Has there been recent research on the long-term use of Codeine Phosphate?

A: Official regulatory reviews, particularly in jurisdictions like the UK and Australia, have focused on the risks associated with long-term use. These reviews note that taking codeine regularly for a prolonged period can lead to physical dependence. Consequently, official guidance emphasizes using the drug only for the shortest possible duration.

Q: What evidence exists about the use of Codeine Phosphate in chronic pain?

A: Regulatory reviews indicate that codeine may be used in managing both acute and chronic pain as part of a multi-modal treatment plan. However, due to official safety constraints and the documented risks of dependence and misuse, regulatory guidance focuses primarily on its use for short-term pain relief.

Q: Is Codeine Phosphate likely to cause withdrawal symptoms if stopped suddenly?

A: If Codeine Phosphate is stopped suddenly, particularly after regular or prolonged use, it may lead to withdrawal symptoms. These symptoms, which are documented in official information, can include physical effects like sweating, shaking, body aches, and psychological effects such as feeling anxious or restless.

Q: What if I'm taking other prescription medications—how do I check for interactions?

A: Official information consistently references the need to inform your healthcare provider about all prescription, over-the-counter, and herbal products being taken. Additionally, government-backed drug information databases, such as DailyMed or MedlinePlus, are available for patients to look up detailed interaction lists.

Q: Does Codeine Phosphate interact with herbal supplements?

A: Yes, regulatory documents note that specific herbal and nonprescription products may interact with Codeine Phosphate. Examples of supplements that are noted to interact include St. John’s wort and tryptophan.

Q: Is it okay to take Codeine Phosphate if I have high blood pressure?

A: Official safety warnings generally list low blood pressure (hypotension) as a condition where caution is required during use. High blood pressure (hypertension) is not typically cited in regulatory documents as an absolute contraindication for Codeine Phosphate.

Q: Why is Codeine Phosphate use restricted for some users in certain regions?

A: Regulatory agencies in various countries have implemented restrictions on the duration of use to minimize public health risks. These restrictions are in place to reduce the potential for addiction, abuse, and dependence, and to limit patient exposure to the drug's potential serious side effects.

Q: Is Codeine Phosphate a generic or brand-name drug?

A: Codeine phosphate is the generic name for the active pharmaceutical ingredient. It is available from manufacturers as a generic drug, often in combination with other analgesics, and has also been marketed throughout its history under various brand names.

Q: What are the regulatory classifications for Codeine Phosphate regarding safety?

A: From a safety and legal perspective, Codeine Phosphate is classified as a controlled substance by government authorities. The exact control schedule it is placed under can vary, typically ranging from Schedule II to V, depending on the drug's specific formulation and concentration.

Q: Are there non-opioid medications that work similarly to Codeine Phosphate?

A: Official guidelines indicate that codeine is primarily used when less potent pain relievers are insufficient. The common non-opioid analgesics that are often used before codeine, and sometimes in combination with it, include acetaminophen (paracetamol) and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen.

Q: Does Codeine Phosphate cause tolerance over time?

A: Yes, regulatory documents explicitly state that tolerance to codeine can develop with continued use. Tolerance is a physiological process where the body adapts to the drug, meaning that a higher dose may be required to achieve the same therapeutic effect over time.

Q: Do studies support Codeine Phosphate use for breakthrough pain?

A: Codeine is classified as a mild opioid on the World Health Organization's Pain Relief Ladder. While not an official indication, this classification places it as a step in managing pain that is not fully controlled, which can include the management of pain that flares up suddenly (breakthrough pain).

Q: What does 'contraindication' mean in the context of Codeine Phosphate?

A: A contraindication is a condition or factor that makes a particular medical treatment, like Codeine Phosphate, potentially harmful. When a condition is listed as a contraindication, it is an official reason to withhold the drug because its use could potentially cause significant harm or serious adverse consequences.

Q: Can Codeine Phosphate cause changes in appetite?

A: Official documents list loss of appetite as a potential side effect associated with the use of codeine. This effect is often documented alongside other common gastrointestinal reactions like nausea and vomiting.

Q: What are common patient concerns regarding the use of Codeine Phosphate?

A: Official warnings and patient information often highlight common concerns related to its use. The primary concerns include the risks of addiction, abuse, and misuse, the potential for serious side effects like respiratory depression, and the possibility that the drug may not be effective for all individuals due to genetic variability.

Q: Is Codeine Phosphate suitable for individuals with a history of substance use disorder?

A: Regulatory warnings indicate that the risks of addiction, abuse, and misuse are increased in patients who have a personal or family history of substance abuse. Official guidance highlights the need for close monitoring and caution in these situations, watching for any signs of misuse or addiction.

How should Codeine Phosphate be stored and disposed of?

How to Store and Dispose of Codeine Phosphate

Codeine phosphate must be stored under specific environmental conditions to ensure its integrity and stability, as required by regulatory labeling.

Official Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, typically 68 F to 77 F (20 C to 25 C).
Protection Must be protected from light and moisture.
Container Keep in the original container and ensure it is kept tightly closed.
Safety Must be stored out of the sight and reach of children.

Disposal

Unused or expired codeine phosphate must be disposed of according to local regulations, often utilizing drug take-back programs at pharmacies or police stations. The medicine must not be flushed down the toilet or poured down a sink unless explicitly specified by government disposal guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Codeine Phosphate found in:

A-Z Index: